IVDR Transition Extension Was Officially Published
In July 2024, the EU published changes extending parts of the transition from the In Vitro Diagnostic Medical Devices Directive (IVDD) to the In Vitro Diagnostic Medical Devices Regulation (IVDR). The extension gave qualifying legacy devices additional time, subject to conditions. It did not give every IVDD device or importer automatic permission to continue placing products on the EU market.
Which Devices Could Use the Extended Transition?
The 2024 changes concerned qualifying legacy in vitro diagnostic devices, including devices covered by relevant IVDD notified-body certificates and certain devices with an IVDD declaration of conformity that require notified-body involvement under the IVDR. Eligibility also depends on the cumulative conditions set out in the legislation, including no significant change in design or intended purpose and no unacceptable risk to health or safety.
The extended end dates identified in the 2024 update were 31 December 2027 for qualifying class D devices, 31 December 2028 for qualifying class C devices, and 31 December 2029 for qualifying class B and class A sterile devices. Class A non-sterile devices do not gain this legacy transition route. An end date is not a substitute for checking the earlier application, agreement and quality-management milestones.
Application, Agreement and QMS Milestones
The 2024 article set out staged application deadlines: 26 May 2025 for devices covered by relevant IVDD certificates and qualifying class D devices, 26 May 2026 for qualifying class C devices, and 26 May 2027 for qualifying class B and class A sterile devices. The associated written-agreement deadlines were described as four months later: 26 September 2025, 26 September 2026 and 26 September 2027, respectively. The manufacturer’s IVDR-compliant quality management system was another milestone for continued transition.
Several of these dates are now in the past. Manufacturers and importers should establish whether the applicable steps were actually completed on time, rather than assuming that a later transition end date can cure a missed milestone. Check the current official text and the circumstances of the specific device.
What Manufacturers Should Verify
- Device history: confirm the relevant IVDD declaration or certificate and the device’s classification under the IVDR.
- Transition conditions: document the device’s continued compliance, changes to its design or intended purpose, and applicable safety and surveillance obligations.
- Process milestones: retain evidence of the quality management system, formal notified-body application and written agreement where required.
- Current status: review the latest official guidance, certificate status and device-specific documentation before placing additional units on the market.
The extension is a route for certain legacy devices while they progress toward IVDR conformity assessment. It is not an assurance that a device already has an IVDR CE certificate, nor should obtaining such a certificate be confused with continued use of the legacy route.
What Importers Should Check
An importer can use the additional time to coordinate with the manufacturer, but must verify the legal basis on which each device is placed on the market. Useful checks include the manufacturer’s transition evidence, applicable declaration or certificate, labeling and instructions, traceability records and a process for handling complaints and corrective actions. The specific importer duties and documents depend on the device and the applicable rules.
Official Guidance and Further Reading
For the extension conditions, see the European Commission’s IVDR transition Q&A. The link in the earlier version of this article points to MDCG guidance on IVDR classification rules, which is useful for classification but is not itself the transition-extension document. Confirm that the documents and legal text you rely on are current before making a device-specific decision.
WE RECOMMEND
Related posts
- Subscribe MedInsights
- Subscribe MedInsights
- Subscribe MedInsights
- Subscribe MedInsights
- Subscribe MedInsights





